Evaluation of Chemotherapy Regimen Management Practice by Oncology-Specialized and Non-specialized Pharmacists Collaboration

Saito, Yoshitaka; Uchiyama, Kazuki; Sakamoto, Tatsuhiko; Kubota, Kosei; Oki, Hiromitsu; Iwai, Miwako; Takekuma, Yoh; Komatsu, Yoshito; Sugawara, Mitsuru

Evaluation of Chemotherapy Regimen Management Practice by Oncology-Specialized and Non-specialized Pharmacists Collaboration

Saito, Yoshitaka; Uchiyama, Kazuki; Sakamoto, Tatsuhiko et al.

Biological & pharmaceutical bulletin, 2021, 44(3), 293-297

Permalink : https://hdl.handle.net/2115/81452

このアイテムのアクセス数:516件（2026-08-16 12:50 集計）

閲覧可能ファイル

ファイル	フォーマット	サイズ	閲覧回数	説明
https://doi.org/10.1248/bpb.b20-00872			8

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

アクセス権	open access
URI	https://hdl.handle.net/2115/81452
タイトル	Evaluation of Chemotherapy Regimen Management Practice by Oncology-Specialized and Non-specialized Pharmacists Collaboration
著者	Saito, Yoshitaka ; Uchiyama, Kazuki ; Sakamoto, Tatsuhiko ; Kubota, Kosei ; Oki, Hiromitsu ; Iwai, Miwako ; Takekuma, Yoh ; Komatsu, Yoshito ; Sugawara, Mitsuru
e-Rad_Researcher 00835001 著者名 Saito, Yoshitaka
著者名 Uchiyama, Kazuki
著者名 Sakamoto, Tatsuhiko
著者名 Kubota, Kosei
著者名 Oki, Hiromitsu
著者名 Iwai, Miwako
e-Rad_Researcher 00396293 著者名 Takekuma, Yoh
e-Rad_Researcher 60333598 著者名 Komatsu, Yoshito
e-Rad_Researcher 60332467 著者名 Sugawara, Mitsuru
言語	英語
キーワード	chemotherapy regimen management
	regimen review
	phannaceutical care
	safety management
	oncology-certified pharmacist
	practice sharing
発行日	2021-03-01
出版者	The Pharmaceutical Society of Japan
出版者	日本薬学会
収録物名	Biological & pharmaceutical bulletin
巻(号)	44(3)
ページ	293-297
抄録	Chemotherapy regimen management is one of the most important oncology pharmacy practices, because chemotherapy is conducted according to the registered regimens. In this study, we evaluated the pharmaceutical practice that assumes the initial confirmation of chemotherapy regimens and the quality of practice sharing between oncology-specialized and non-specialized pharmacists in regimen management committee. Pharmacists initially confirmed the applied regimen prescribed by physicians regarding chemotherapeutic agents and prophylactic supportive care medicines. Following confirmation, the regimens were reviewed by the Hokkaido University Hospital Regimen Management Committee. A total of 233 regimens were reviewed by the committee over three years. In total, 110 pharmaceutical inquiries were conducted, 45% of inquiries were concerning chemotherapeutic agents, of which approximately half were regarding supportive care medicines. Most inquiries were regarding premedication, followed by those on administration time, solvent of infusion medicines, and dosage. Correction was performed for 84.5% of inquiries. There was no significant difference in inquiry rates between practice and trial regimens. We have entrusted the first basic regimen review according to the checklist, creation of the chemotherapy plan document, and registry of the adopted regimens in the ordering system from oncology-certified pharmacists to non-certified pharmacists. Basic regimen review was well conducted by a non-certified pharmacist, and a more advanced review was additionally performed by certified pharmacists. In conclusion, we demonstrated the utility of pharmaceutical confirmation in a chemotherapeutic regimen review, suitable review coverage, and quality practice sharing between oncology-certified and non-certified pharmacists, which is one of the recommended methods in chemotherapy regimen review.
資源タイプ	学術雑誌論文
出版タイプ	Version of Record
PISSN	0918-6158
EISSN	1347-5215
関連情報 (isIdenticalTo)	出版社版DOI https://doi.org/10.1248/bpb.b20-00872